Corresponding Author: Elie Azoulay, MD, PhD, Médecine Intensive et Réanimation, APHP, Hôpital Saint-Louis, Paris University, 1 Avenue Claude Vellefaux, 75010 Paris, France (elie.azoulay@aphp.fr).
Accepted for Publication: February 2, 2022.
Published Online: February 18, 2022. doi:10.1001/jama.2022.2017
Author Contributions: Drs Azoulay and Resche-Rigon had full access to all of the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis.
Concept and design: Azoulay, Resche-Rigon, Geri, Quenot, Lesieur, Demoule, Guitton, Biard, Pochard, Kentish-Barnes.
Acquisition, analysis, or interpretation of data: Azoulay, Megarbane, Reuter, Labbé, Cariou, Geri, Van der Meersch, Kouatchet, Guisset, Bruneel, Reignier, Souppart, Barbier, Argaud, Quenot, Papazian, Guidet, Thiéry, Klouche, Lesieur, Demoule, Guitton, Capellier, Mourvillier, Biard, Pochard, Kentish-Barnes.
Drafting of the manuscript: Azoulay, Resche-Rigon, Quenot, Lesieur, Biard, Pochard, Kentish-Barnes.
Critical revision of the manuscript for important intellectual content: All authors.
Statistical analysis: Resche-Rigon, Lesieur, Demoule, Biard.
Obtained funding: Azoulay, Resche-Rigon.
Administrative, technical, or material support: Resche-Rigon, Souppart, Lesieur, Guitton, Mourvillier.
Supervision: Azoulay, Guisset, Bruneel, Quenot, Guidet, Thiéry, Klouche, Lesieur, Guitton, Capellier, Mourvillier, Pochard, Kentish-Barnes.
Conflict of Interest Disclosures: Dr Azoulay reported receipt of personal fees (lectures) from Pfizer, Gilead, Baxter, and Alexion; and institutional research grants from Merck Sharp and Dohme, Pfizer, Baxter, and Alexion outside the submitted work. Dr Labbé reported personal fees from Amomed and grants from LeoPharma outside the submitted work. Dr Cariou reported personal fees from Bard outside the submitted work. Dr Souppart reported grants from French Ministry of Health during the conduct of the study. Dr Barbier reported personal fees from Merck Sharp and Dohme and BioMérieux outside the submitted work. Dr Papazian reported personal fees from Air Liquide Santé and Gettinge and grants from SEDANA outside the submitted work. Dr Thiéry reported personal fees from Amgen outside the submitted work. Dr Demoule reported grants from the French Ministry of Health; grants and personal fees from Philips, Fisher & Paykel, Respinor, and Lungpacer; personal fees from Baxter, Getinge, Gilead, and Lowenstein; and nonfinancial support from Fisher & Paykel outside the submitted work. Dr Capellier reported grants from ASTEN and Baxter; other from Freysenius (conference fees); and personal fees from ARCHEON outside the submitted work. Dr Kentish-Barnes reported grants from French Ministry of Health during the conduct of the study and outside the submitted work. No other disclosures were reported.
Funding/Support: All financial support for the research was provided by the French Ministry of Health.
Role of the Funder/Sponsor: The French Ministry of Health had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.
Additional Contributions: We thank all members of the team from the clinical research unit of the Saint-Louis Hospital: Anne-Juliette Trouiller, MS (senior research assistant), El Mountacer El Abassi, PhD (project manager), Marine Cognat, MS (research coordinator), Zakaria Maakoul, MS (research coordinator), Amine Hanachi, MS (research coordinator), Malika Ghartouchant, MS (research coordinator), and Fatima Ait Seddik, MS (research coordinator); and members from the critical care department of the Saint-Louis Hospital: Philonille Degos, MS, and Clémence Viau, MS, for their help and engagement in the study. None of these individuals received a dedicated compensation for their role in the study.
Additional Information: This study was performed on behalf of the Famirea Study Group.
1.Piroth
L , Cottenet
J , Mariet
A-S ,
et al. Comparison of the characteristics, morbidity, and mortality of COVID-19 and seasonal influenza: a nationwide, population-based retrospective cohort study.
Lancet Respir Med. 2021;9(3):251-259. doi:
10.1016/S2213-2600(20)30527-0PubMedGoogle ScholarCrossref 2.Writing Committee for the COMEBAC Study Group; Morin
L , Savale
L , Pham
T ,
et al. Four-month clinical status of a cohort of patients after hospitalization for COVID-19.
JAMA. 2021; 325(15):1525-1534. doi:
10.1001/jama.2021.3331PubMedGoogle Scholar 4.Herridge
MS , Cheung
AM , Tansey
CM ,
et al; Canadian Critical Care Trials Group. One-year outcomes in survivors of the acute respiratory distress syndrome.
N Engl J Med. 2003;348(8):683-693. doi:
10.1056/NEJMoa022450PubMedGoogle ScholarCrossref 5.Cameron
JI , Chu
LM , Matte
A ,
et al; RECOVER Program Investigators (Phase 1: towards RECOVER); Canadian Critical Care Trials Group. One-year outcomes in caregivers of critically ill patients.
N Engl J Med. 2016;374(19):1831-1841. doi:
10.1056/NEJMoa1511160PubMedGoogle ScholarCrossref 7.Zubair
AS , McAlpine
LS , Gardin
T , Farhadian
S , Kuruvilla
DE , Spudich
S . Neuropathogenesis and neurologic manifestations of the coronaviruses in the age of coronavirus disease 2019: a review.
JAMA Neurol. 2020;77(8):1018-1027. doi:
10.1001/jamaneurol.2020.2065PubMedGoogle ScholarCrossref 8.Robert
R , Le Gouge
A , Kentish-Barnes
N ,
et al Terminal weaning or immediate extubation for withdrawing mechanical ventilation in critically ill patients (the ARREVE observational study).
Intensive Care Med. 2017;43(12):1793-1807. doi:
10.1007/s00134-017-4891-0PubMedGoogle ScholarCrossref 11.Pochard
F , Azoulay
E , Chevret
S ,
et al; French FAMIREA Group. Symptoms of anxiety and depression in family members of intensive care unit patients: ethical hypothesis regarding decision-making capacity.
Crit Care Med. 2001;29(10):1893-1897. doi:
10.1097/00003246-200110000-00007PubMedGoogle ScholarCrossref 14.Ware
JE
Jr , Kosinski
M , Bayliss
MS , McHorney
CA , Rogers
WH , Raczek
A . Comparison of methods for the scoring and statistical analysis of SF-36 health profile and summary measures: summary of results from the Medical Outcomes Study.
Med Care. 1995;33(4)(suppl):AS264-AS279.
PubMedGoogle Scholar 15.Peyre
H , Leplège
A , Coste
J . Missing data methods for dealing with missing items in quality of life questionnaires: a comparison by simulation of personal mean score, full information maximum likelihood, multiple imputation, and hot deck techniques applied to the SF-36 in the French 2003 decennial health survey.
Qual Life Res. 2011;20(2):287-300. doi:
10.1007/s11136-010-9740-3PubMedGoogle ScholarCrossref 18.Hosmer
DW , Lemeshow
S .
Applied Logistic Regression. John Wiley and Sons; 2000. doi:
10.1002/0471722146 23.Rosa
RG , Falavigna
M , da Silva
DB ,
et al; ICU Visits Study Group Investigators and the Brazilian Research in Intensive Care Network (BRICNet). Effect of flexible family visitation on delirium among patients in the intensive care unit: the ICU Visits randomized clinical trial.
JAMA. 2019;322(3):216-228. doi:
10.1001/jama.2019.8766PubMedGoogle ScholarCrossref